Sevilla-González, Magdalena https://orcid.org/0000-0001-6135-9998
Smith, Kirk
Wang, Ningyuan
Jensen, Aubrey E.
Litkowski, Elizabeth M. https://orcid.org/0000-0002-7079-696X
Kim, Hyunkyung https://orcid.org/0000-0001-7964-3073
DiCorpo, Daniel A.
Hsu, Sarah
Cui, Jinrui
Liu, Ching-Ti https://orcid.org/0000-0002-0703-0742
Yu, Chenglong https://orcid.org/0000-0002-0546-2779
McNeil, John J. https://orcid.org/0000-0002-1049-5129
Lacaze, Paul https://orcid.org/0000-0002-0902-6798
Westerman, Kenneth E. https://orcid.org/0000-0001-7619-1868
Chang, Kyong-Mi https://orcid.org/0000-0001-6811-9364
Tsao, Philip S. https://orcid.org/0000-0001-7274-9318
Phillips, Lawrence S. https://orcid.org/0000-0002-6542-8046
Goodarzi, Mark O. https://orcid.org/0000-0001-6364-5103
Sladek, Rob
Rotter, Jerome I. https://orcid.org/0000-0001-7191-1723
Dupuis, Josée https://orcid.org/0000-0003-2871-3603
Florez, Jose C. https://orcid.org/0000-0002-1730-9325
Merino, Jordi https://orcid.org/0000-0001-8312-1438
Meigs, James B.
Zhou, Jin J.
Raghavan, Sridharan
Udler, Miriam S. https://orcid.org/0000-0003-3824-9162
Manning, Alisa K. https://orcid.org/0000-0003-0247-902X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (UM1DK078616)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL151855)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U01HG011723)
Article History
Received: 30 April 2024
Accepted: 21 February 2025
First Online: 15 March 2025
Competing interests
: J.C.F. gets consulting honoraria from Novo Nordisk and AstraZeneca; speaker honoraria from Novo Nordisk, AstraZeneca, and Merck for research lectures over which J.C.F. had full control on content. J.B.M. is an Academic Associate for Quest Diagnostics’ endocrine R&D. The remaining authors declare no competing interests.